Literature DB >> 9102622

[Cryoglobulinemia in chronic liver diseases: cause or consequence?].

A Csepregi1, E Nemesánszky.   

Abstract

Cryoglobulinemia occurs in a wide spectrum of infectious, autoimmune, neoplastic, renal and liver diseases. In the first part of the publication the authors give a review about laboratory and clinical features of cryoglobulinemia and its associated syndromes. In essential mixed cryoglobulinemia (arthralgia-purpura-weakness) clinical and laboratory evidence of liver involvement are frequently found. In chronic liver diseases of different etiologies mixed cryoglobulins can be detected. In 30-94% of cases of chronic hepatitis C virus infection and chronic liver diseases related to hepatitis C virus laboratory signs (and occasionally clinical symptoms as well) of mixed cryoglobulins have recently been reported. In the cryoprecipitates of these cryoglobulins positive patients markers of hepatitis C virus have been detected. The presence of high prevalence of cryoglobulins in chronic hepatitis C virus infection and chronic liver diseases related to hepatitis C virus suggests a significant role for this hepatotropic virus in the pathogenesis of mixed cryoglobulins. On the other side, the impact of impaired liver function in the clearance of (cryo)immunocomplexes from the serum can be a causative factor in the production of cryoproteins in chronic liver disease of different etiologies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9102622

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association?

Authors:  Benjamin C Bryson; Paul Angulo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of direct-acting antiviral therapy.

Authors:  Ann W N Auma; Corinne Kowal; Carey L Shive; Alyssa Lange; Sofi Damjanovska; Elizabeth Zebrowski; Elane Reyes; Leonard Calabrese; Lenche Kostadinova; Yngve Falck-Ytter; Maya Mattar; Donald D Anthony
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.